Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study

The aim of this study was to define the maximum tolerated dose (MTD) of bolus mitomycin C (MMC) in combination with 24 h-continuous infusion of 5-flourouracil (FU) plus folinic acid, and to assess the toxicity and activity in patients with previously treated colorectal and gastric cancer. Escalating...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hartmann, J T, Oechsle, K, Quietzsch, D, Wein, A, Hofheinz, R D, Honecker, F, Nehls, O, Köhne, C-H, Käfer, G, Kanz, L, Bokemeyer, C
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2003
Gaiak:
Clinical
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2376864/
https://ncbi.nlm.nih.gov/pubmed/14647137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601412
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak